SARS-COV-2 (COVID-19) vaccine, vector - Ad26
RxNorm 2479830

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 2479830 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: SARS-COV-2 (COVID-19) vaccine, vector - Ad26.

The following semantic concepts and normalized strings are associated with this clinical entity:

PIN
SARS-COV-2 (COVID-19) vaccine, vector - Ad26
AUI:12540920
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

PIN

Precise Ingredient (PIN):
SARS-COV-2 (COVID-19) vaccine, vector - Ad26
(Atom ID: 12540920)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
SARS-COV-2 (COVID-19) vaccine, vector - Ad26
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2479830
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12540920
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PIN
Precise Ingredient (A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms.)
Source Code
2479830
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Patient Education

COVID-19 Vaccine, Viral Vector (Janssen [Johnson and Johnson])


What is COVID-19? COVID-19 disease is caused by a coronavirus called SARS-CoV-2. This type of coronavirus has not been seen before. You can get COVID-19 through contact with another person who has the virus. It is predominantly a respiratory (lung) illness that can affect other organs. People with COVID-19 have had a wide range of symptoms reported, ranging from mild symptoms to severe illness. Symptoms may appear 2 to 14 days after exposure to the virus. Symptoms may include: fever, chills, cough, shortness of breath, fatigue, muscle or body aches, headache, loss of taste or smell, sore throat, congestion, runny nose, nausea, vomiting, or diarrhea.
[Learn More]


COVID-19 Vaccines


COVID-19 (coronavirus disease 2019) is an illness caused by a virus. This virus is a new coronavirus that has spread throughout the world. In the United States, there are several authorized and recommended vaccines to prevent COVID-19. These vaccines are being used under Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). These FDA decisions mean that the vaccines met the FDA's scientific standards for safety, effectiveness, and manufacturing quality needed to support EUA.

This page includes details about the vaccines and the vaccination program, including where you can find a vaccine. You can also find information about other COVID-19 vaccines that are still in progress. This includes details on how to volunteer for a vaccine clinical trial.

Centers for Disease Control and Prevention


[Learn More]


* Please review the disclaimer below.